​Another outstanding educational event brought to you by the ITAE Group.  

Copyright 2020.

We are GDPR compliant, to view our privacy policy and how we handle your data please click here.


How long does the VIVIT dissection last?

The post mortem experience is 5 hours long, split into 2 parts.

How many people can participate in one VIVIT dissection?

There is 150 tickets available for each session. This is a comfortable number that can engage with the experience given the AV equipment installed.

Is the anatomy human?

No. The anatomy is of swine origin. Identical in size and structure -once harvested the samples are moved into VIVIT. VIVIT is a life size synthetic cadaver which is dissected for the audience to teach the structure and function of the human body.


Anatomy Lab.png

Tickets purchased directly from us are sold subject to our terms and conditions. All tickets purchased are non-refundable and non-transferable. Download terms and conditions here.

Some event content may vary from the guideline programmes and content descriptions are for guideline purposes only. Right to amend or change content before/during the experience reserved.

Second man cured of HIV

A man in London has become the second ever known person to be cleared of HIV after receiving a bone marrow transplant from a donor resistant to the disease.

The patient received a bone marrow transplant 3 years ago from a donor with a rare genetic mutation that resists the HIV infection, 18 months after the transplant the patient was able to come off his antiretroviral drugs. With recently conducted tests still showing no trace of his previous HIV infection.

“There is no virus there that we can measure. We can’t detect anything,” said Ravindra Gupta, a professor and HIV biologist who co-led a team of doctors treating the man. He described his patient as “functionally cured” and “in remission”, but cautioned: “It’s too early to say he’s cured.“

This is the second known case of a functional cure for HIV. American Timothy Brown who received similar treatment in back in 2007 in Germany. He was also cleared of the HIV virus and is still HIV-free.

Statistics suggest that 37 million people are infected with HIV and Aids globally, resulting in 35million people deaths from the disease since in the 1980s. Though both patients have been cured of the virus, experts say that the procedure is still expensive, complex and risky to be rolled out worldwide. Exact match donors would have to be found in the tiny proportion of people – most of them of northern European descent – who have the CCR5 mutation.

Specialists said it was not yet clear whether the CCR5 resistance is the only key – or whether the graft-versus-host disease may have been just as important. The Berlin and London patients both had this complication, which may have played a role in the loss of HIV-infected cells.

He said his team planned to use these findings to explore potential HIV treatment strategies. “We need to understand if we could knock out this [CCR5] receptor in people with HIV, which may be possible with gene therapy,” he said.